NRIX earnings — third quarter fiscal 2026 (released October 12; calendar-listed October 11)

Catalyst

NRIX earnings — third quarter fiscal 2026 (released October 12; calendar-listed October 11)

Nurix reported third-quarter results in a press release dated October 12, 2026: revenue of $673.1M and EPS of $4.73, driven by the upfront payment under its Roche collaboration, with operating income of $559.5M and cash runway extended into 2029 (Markets Insider press-release page; Sci-Tech Today). The calendar's October 11 date and its $5.11 "analyst consensus" are provider-calendar fields that the filings and news do not support: MarketBeat's earnings page puts the pre-print consensus at a loss of about $0.60 a share on $24.35M of revenue (single aggregator), so the −7.5% "miss" the calendar implies is not a read of this print.

After the print, Truist cut its price target to $33 from $34 (Buy) and Baird raised its target to $36 from $33 (Outperform), both on October 13 (MarketBeat; Ground News).

Sources

9 events
DateTypeEvent
Oct 12 ScanMonster Scan Oct 12 CatalystNRIX earnings Oct 13 Market BriefA Flat Index Over a Chip Rout, and Cipher's Zero-Coupon Haircut Oct 13 ScanMonster Scan Oct 9 ScanMonster Scan Oct 14 ScanMonster Scan Oct 8 ScanMonster Scan Oct 8 CatalystNRIX earnings Oct 15 ScanMonster Scan

Tweets, videos, filings, articles, and source pages tied to this read.

3
markets.businessinsider.comNurix third-quarter 2026 results press release, via Markets Insider, October 12
marketbeat.comMarketBeat, Nurix Q3 2026 earnings results page, October 12
sci-tech-today.comSci-Tech Today, Nurix Q3 2026 earnings, October 13